For companies entering Australia, approval timelines are often impacted not by the dossier but by manufacturing compliance.
The Therapeutic Goods Administration (TGA) places strong emphasis on Good Manufacturing Practice (GMP), making GMP clearance in Australia a critical step for market access.
GMP Clearance is the TGA’s formal verification that an overseas manufacturing site complies with Australian GMP standards.
It is required before a product can be approved or maintained on the Australian Register of Therapeutic Goods (ARTG).
In simple terms:
No GMP Clearance = No ARTG inclusion or supply
Sponsors must submit evidence such as:
- GMP certificates from recognized authorities
- Inspection reports and compliance history
- Quality system and manufacturing details
- Alignment with PIC/S GMP standards
GMP clearance is one of the most common causes of delays due to:
- Incomplete or outdated GMP documentation
- Delays in coordinating with overseas manufacturers
- Misalignment with TGA expectations
- Dependence on third-party inspection timelines
- Lack of clarity on acceptable evidence pathways
These issues often lead to approval delays and multiple query cycles.
Freyr supports sponsors with focused GMP clearance support, including:
Assessment of GMP documentation and readiness
Identification of gaps against TGA expectations
Coordination support with manufacturers for required evidence
Submission support aligned with ARTG timelines
Integration with broader regulatory and lifecycle activities
Outcome: Reduced bottlenecks, improved submission readiness, and smoother approval pathways.
For global manufacturers, aligning multiple regulatory inspections with Australia requirements can be complex.
Freyr helps streamline this by aligning global GMP evidence with TGA expectations, reducing duplication and delays.
GMP clearance is not just a regulatory checkpoint it’s a critical path dependency for approvals in Australia.
Is your GMP strategy aligned to avoid delays or creating them?
Connect with Freyr to assess your GMP readiness and avoid approval bottlenecks in Australia